Search | MIT Sloan

MIT Sloan logo

Learn about the future of management education. A conversation with John C Head III Dean Rick Locke.

contact

MBA

Through intellectual rigor and experiential learning, this full-time, two-year MBA program develops leaders who make a difference in the world.

Leaders for Global Operations

Earn your MBA and SM in engineering with this transformative two-year program.

Master of Finance

A rigorous, hands-on program that prepares adaptive problem solvers for premier finance careers.

Master of Business Analytics

A 12-month program focused on applying the tools of modern data science, optimization and machine learning to solve real-world business problems.

Master of Science in Management Studies

Combine an international MBA with a deep dive into management science. A special opportunity for partner and affiliate schools only.

PhD

A doctoral program that produces outstanding scholars who are leading in their fields of research.

Undergraduate

Bring a business perspective to your technical and quantitative expertise with a bachelor’s degree in management, business analytics, or finance.

MBA Early (Deferred admissions option)

Apply now and work for two to five years. We'll save you a seat in our MBA class when you're ready to come back to campus for your degree.

Executive Programs

MIT Executive MBA

The 20-month program teaches the science of management to mid-career leaders who want to move from success to significance.

MIT Sloan Fellows MBA

A full-time MBA program for mid-career leaders eager to dedicate one year of discovery for a lifetime of impact.

System Design & Management

A joint program for mid-career professionals that integrates engineering and systems thinking. Earn your master’s degree in engineering and management.

Executive Education

Non-degree programs for senior executives and high-potential managers.

Visiting Fellows

A non-degree, customizable program for mid-career professionals.

11 - 20 out of 301

MIT Sloan Health Systems Initiative

Leveraging Technology in Healthcare Delivery: Overcoming Adoption Barriers

Joanna Brownstein, February 2024 HSI Seminar

MIT Sloan Health Systems Initiative

2024 Sloan Healthcare and BioInnovations Conference Highlights Access to Care

On February 23, 2024, The MIT Sloan Healthcare Club convened the 22nd annual MIT Sloan Healthcare and Bioinnovations Conference.

MIT Sloan Health Systems Initiative

Karishma Sewaramani, MD, MBA ’24 on her experience with MIT Sloan Action Learning

MIT Sloan Action Learning - In each project the ultimate goal is to improve the quality of healthcare and patient outcomes.

MIT Sloan Health Systems Initiative

Two Students from the 2024 Cohort Celebrated at Recent Healthcare Certificate Ceremony

Spotlight on Two Students from the Cohort Celebrated at Recent Healthcare Certificate Ceremony

MIT Sloan Health Systems Initiative

Carl Berke, Partner at Mass General Brigham Ventures, Lessons Learned from Decades of Investing in Life Science Ventures

Carl Berke, Lessons Learned from Decades of Investing in Life Science Ventures

MIT Sloan Health Systems Initiative

The Role of Quality Scores and Subsidies in Improving Patient Care

Improving patients’ quality of care is one of the government’s critical strategic healthcare goals.

MIT Sloan Health Systems Initiative

Spring 2024 Research Updates: Innovative Insights in Hospital Operations, Worker Wellbeing, and the Effect of Social Media

Spring 2024 Research Updates

MIT Sloan Health Systems Initiative

Data Revolution in Healthcare: New Frontiers in Interoperability and Data Exchange With FHIR

New Frontiers in Interoperability and Data Exchange With FHIR

MIT Sloan Health Systems Initiative

Healthcare Lab Poster Session: Eight Student Teams Presented Results of their Real-world Projects

Healthcare Lab, one of the required courses for the MIT Sloan healthcare certificate, is an opportunity for students to gain insight into real-world challenges in healthcare.

MIT Sloan Health Systems Initiative

What to do about AI in health?

Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.